The recent guidelines for pharmacotherapy of Parkinson’s Disease

Abstract

Parkinson’s Disease (PD) is one of the most frequent disorders of the central nervous system (CNS). PD is an age-related disease in that morbidity increases with age. The main symptoms of it are motor symptoms like bradykinesia, rigidity and resting tremor. These symptoms diminish the comfort of the patient’s life and may lead to immobility. Hence, rapid diagnosis and start of treatment are very important.

Keywords

• parkinson’s disease (pd)
• pharmacotherapy of pd
• dopamine agonists
• anticholinergic drugs
• future treatment of pd